APA (7th ed.) Citation

Tilburg, C. M. v., Kilburn, L. B., Perreault, S., Schmidt, R., Azizi, A. A., Cruz-Martínez, O., . . . Witt, O. (2024). LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration. BMC cancer, 24, . https://doi.org/10.1186/s12885-024-11820-x

Chicago Style (17th ed.) Citation

Tilburg, Cornelis M. van, et al. "LOGGIC/FIREFLY-2: A Phase 3, Randomized Trial of Tovorafenib Vs. Chemotherapy in Pediatric and Young Adult Patients with Newly Diagnosed Low-grade Glioma Harboring an Activating RAF Alteration." BMC Cancer 24 (2024). https://doi.org/10.1186/s12885-024-11820-x.

MLA (9th ed.) Citation

Tilburg, Cornelis M. van, et al. "LOGGIC/FIREFLY-2: A Phase 3, Randomized Trial of Tovorafenib Vs. Chemotherapy in Pediatric and Young Adult Patients with Newly Diagnosed Low-grade Glioma Harboring an Activating RAF Alteration." BMC Cancer, vol. 24, 2024, https://doi.org/10.1186/s12885-024-11820-x.